Document
BENDAMUSTINE HYDROCHLORIDE, 205580, Label (Orange Book May. 15, 2018)
Cite Document
BENDAMUSTINE HYDROCHLORIDE, 205580, Label (Orange Book May. 15, 2018)
+ More Snippets
Document
BELRAPZO, 205580, Review Medical Reviews (Orange Book May. 15, 2018)
Cite Document
BELRAPZO, 205580, Review Medical Reviews (Orange Book May. 15, 2018)
+ More Snippets
Document
BELRAPZO, 205580, Review Chemistry Reviews (Orange Book May. 15, 2018)
Cite Document
BELRAPZO, 205580, Review Chemistry Reviews (Orange Book May. 15, 2018)
+ More Snippets
Document
TREANDA, 022249, Letter (Orange Book Dec. 15, 2017)
Cite Document
TREANDA, 022249, Letter (Orange Book Dec. 15, 2017)
+ More Snippets
Document
TREANDA, 022249, Label (Orange Book Dec. 15, 2017)
Cite Document
TREANDA, 022249, Label (Orange Book Dec. 15, 2017)
+ More Snippets
Document
BENDAMUSTINE PHARMACEUTICAL COMPOSITIONS, 13/969,724, No. 1-1-US-139697241OP1 (U.S. Pat. App. May. 15, 2018)
Cite Document
BENDAMUSTINE PHARMACEUTICAL COMPOSITIONS, 13/969,724, No. 1-1-US-139697241OP1 (U.S. Pat. App. May. 15, 2018)
+ More Snippets
Document
BENDAMUSTINE PHARMACEUTICAL COMPOSITIONS, 13/969,724, No. 1-3-US-139697241NP1 (U.S. Pat. App. Apr. 4, 2018)
Cite Document
BENDAMUSTINE PHARMACEUTICAL COMPOSITIONS, 13/969,724, No. 1-3-US-139697241NP1 (U.S. Pat. App. Apr. 4, 2018)
+ More Snippets
Docket
022249,
Orange Book
(March 20, 2008)
Cite Docket
TREANDA, 022249 (Orange Book)
+ More Snippets
Document
BENDAMUSTINE PHARMACEUTICAL COMPOSITIONS, 13/969,724, No. 1-3-US-139697241MP1 (U.S. Pat. App. Jan. 3, 2018)
Cite Document
BENDAMUSTINE PHARMACEUTICAL COMPOSITIONS, 13/969,724, No. 1-3-US-139697241MP1 (U.S. Pat. App. Jan. 3, 2018)
+ More Snippets
Document
BENDAMUSTINE PHARMACEUTICAL COMPOSITIONS, 13/969,724, No. 1-3-US-139697241LP1 (U.S. Pat. App. Dec. 29, 2017)
Cite Document
BENDAMUSTINE PHARMACEUTICAL COMPOSITIONS, 13/969,724, No. 1-3-US-139697241LP1 (U.S. Pat. App. Dec. 29, 2017)
+ More Snippets
Document
BENDAMUSTINE PHARMACEUTICAL COMPOSITIONS, 13/969,724, No. 1-1-US-139697241KP1 (U.S. Pat. App. Dec. 28, 2017)
Cite Document
BENDAMUSTINE PHARMACEUTICAL COMPOSITIONS, 13/969,724, No. 1-1-US-139697241KP1 (U.S. Pat. App. Dec. 28, 2017)
+ More Snippets
Document
BENDAMUSTINE PHARMACEUTICAL COMPOSITIONS, 13/969,724, No. 1-1-US-139697241HP1 (U.S. Pat. App. Dec. 5, 2017)
Cite Document
BENDAMUSTINE PHARMACEUTICAL COMPOSITIONS, 13/969,724, No. 1-1-US-139697241HP1 (U.S. Pat. App. Dec. 5, 2017)
+ More Snippets
Document
BENDAMUSTINE PHARMACEUTICAL COMPOSITIONS, 13/969,724, No. 1-1-US-139697241IP1 (U.S. Pat. App. Dec. 5, 2017)
Cite Document
BENDAMUSTINE PHARMACEUTICAL COMPOSITIONS, 13/969,724, No. 1-1-US-139697241IP1 (U.S. Pat. App. Dec. 5, 2017)
+ More Snippets
Document
BENDAMUSTINE PHARMACEUTICAL COMPOSITIONS, 13/969,724, No. 1-1-US-139697241JP1 (U.S. Pat. App. Dec. 5, 2017)
Cite Document
BENDAMUSTINE PHARMACEUTICAL COMPOSITIONS, 13/969,724, No. 1-1-US-139697241JP1 (U.S. Pat. App. Dec. 5, 2017)
+ More Snippets
Document
BENDAMUSTINE PHARMACEUTICAL COMPOSITIONS, 13/969,724, No. 1-1-US-139697241GP1 (U.S. Pat. App. Dec. 5, 2017)
Cite Document
BENDAMUSTINE PHARMACEUTICAL COMPOSITIONS, 13/969,724, No. 1-1-US-139697241GP1 (U.S. Pat. App. Dec. 5, 2017)
+ More Snippets